Preview
Link Preview
Precision Vaccinations
Women's Genital Herpes Risk Reportedly Reduced with Vaginal Gel
According to recent research, women who frequently used a preventive vaginal gel significantly reduced their risk of acquiring genital herpes. This study reanalyzed data collected in a previous study, specifically looking at the subgroup of women that adhered to daily usage of the Tenofovir gel, and their rate of HSV-2 acquisition. Tenofovir, a nucleotide reverse transcriptase inhibitor, is approved in its oral formulation for the treatment of human immunodeficiency virus (HIV) infection and Hepatitis B.
According to recent research, women who frequently used a preventive vaginal gel significantly reduced their risk of acquiring genital herpes. This study reanalyzed data collected in a previous study, specifically looking at the subgroup of women that adhered to daily usage of the Tenofovir gel, and their rate of HSV-2 acquisition. Tenofovir, a nucleotide reverse transcriptase inhibitor, is approved in its oral formulation for the treatment of human immunodeficiency virus (HIV) infection and Hepatitis B.
Issue #3
should be in footer
- Danil Dunaitsev
- Who says? This is a references, it's part of scientific article.
- Declined by admin
- Type of issue
- Rudimentary content not removed
- Reported
- Apr 21, 2019